Workflow
Barclays Says Snowflake’s (SNOW) Strong Run Leaves Limited Upside, Downgrades Stock
Yahoo Finance· 2026-01-15 20:28
Snowflake Inc. (NYSE:SNOW) is one of the Must-Watch AI Stocks on Wall Street. On January 12, Barclays analyst Raimo Lenschow downgraded the stock from Overweight to Equalweight with a price target of $250.00 (from $290.00). Firm analysts are constructive on the stock owing to strong fundamentals, but see limited upside after strong run. While Snowflake has been a “best-in-class-software” stock, the firm believes that much of the strength is now priced into valuation. The AI stock has had one of the stron ...
Magnum Goldcorp Inc. Announces Amendment to Amalgamation Agreement with Atlantico Energy Metals and Warrant Amendments
TMX Newsfile· 2026-01-15 20:28
West Vancouver, British Columbia--(Newsfile Corp. - January 15, 2026) - Magnum Goldcorp Inc. (TSXV: MGI) (the "Company" or "Magnum") is pleased to announce that it has entered into an amending agreement dated January 12, 2026 (the "Amendment") to the amalgamation agreement dated October 27, 2025 (the "Agreement") with Atlantico Energy Metals Corp. ("Atlantico") to acquire all of the outstanding shares of Atlantico (the "Transaction"), previously disclosed in the Company's news release dated October 28, 202 ...
Exclusive: IMF's Georgieva says central bank independence critical, backs Powell
Reuters· 2026-01-15 20:27
International Monetary Fund chief Kristalina Georgieva on Thursday underscored the importance of keeping central banks independent and threw her support behind beleaguered Federal Reserve Chair Jerome Powell, who is facing a Trump administration investigation for renovation cost overruns. ...
H.B. Fuller targets $630M–$660M adjusted EBITDA for 2026 while advancing margin expansion strategy (NYSE:FUL)
Seeking Alpha· 2026-01-15 20:27
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
3 Unstoppable Monopolies You Should be Buying Now
247Wallst· 2026-01-15 20:26
Monopolies, we're told, are bad things. ...
Weibo Corporation: Has Enough Going For It To Take It Higher (NASDAQ:WB)
Seeking Alpha· 2026-01-15 20:26
Weibo Corporation ( WB ), a social media platform in China, has not done all that well in recent months as far as the stock is concerned. WB actually saw its stock price decrease by double digitsWelcome to my author's site. As an avid follower of SeekingAlpha, I take great interest in articles posted as the subject matter is often something that appeals to me. However, I will sometimes encounter an article that I might not agree with. My purpose is to present an alternative view to readers that they may wan ...
Weibo Corporation: Has Enough Going For It To Take It Higher
Seeking Alpha· 2026-01-15 20:26
Core Viewpoint - Weibo Corporation (WB) has experienced a significant decline in its stock price, with a decrease in double digits in recent months [1]. Company Summary - Weibo Corporation is a social media platform based in China [1]. - The company's stock performance has been underwhelming, indicating potential challenges in its market position [1].
Zevra Therapeutics, Inc. (ZVRA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Seeking Alpha· 2026-01-15 20:26
PresentationSusmita Roy Good morning, everyone. My name is Susmita Roy. I'm an associate on the JPMorgan Healthcare Investment Banking team. On behalf of JPMorgan, thank you all for attending the Healthcare Conference. And I'm thrilled and honored to introduce Zevra Therapeutics for their company presentation today. A little bit about Zevra before we get started. Zevra Therapeutics is a commercial-stage company with a unique opportunity to impact people living with rare diseases. The company is in growth mo ...
Opus Genetics, Inc. (IRD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Seeking Alpha· 2026-01-15 20:26
PresentationSusmita Roy Good morning, everyone. My name is Susmita Roy, and I'm an associate on the JPMorgan Healthcare Investment Banking team. On behalf of JPMorgan, I would like to thank everyone for attending the Healthcare Conference this year. And I'm pleased and honored to introduce Opus Genetics for the company presentation today. A bit about Opus Genetics. It is a clinical stage biopharmaceutical company developing gene therapies for inherited retinal diseases, trading under the ticker symbol IRD. ...
Dianthus Therapeutics, Inc. (DNTH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Seeking Alpha· 2026-01-15 20:26
PresentationGood afternoon, everyone. I hope you're enjoying the first day of the conference and all the festivities. My name is Alex Buckley. I'm with the Healthcare Investment Banking Group, and it's my pleasure to introduce Dianthus Therapeutics, and Marino Garcia, CEO. We'll have some time at the end for Q&A. If you could just raise your hand, and there will be a mic that goes around.Marino GarciaPresident, CEO & Director Thank you, Alex, and thank you to JPMorgan for the opportunity to present today an ...